pca 4248 has been researched along with Leukocyte Disorders in 1 studies
PCA 4248: structure given in first source; platelet activating factor antagonist
Leukocyte Disorders: Disordered formation of various types of leukocytes or an abnormal accumulation or deficiency of these cells.
Excerpt | Relevance | Reference |
---|---|---|
"Zymosan-induced articular hyperalgesia, oedema and neutrophil migration were dose-dependently reduced following pretreatment with selective PAFR antagonists, UK74505 (5, 10 and 20 mg/kg) and PCA4248 (3, 10, 30 mg/kg)." | 1.39 | The role of PAF/PAFR signaling in zymosan-induced articular inflammatory hyperalgesia. ( Cunha, FQ; Cunha, TM; Ferreira, SH; Guerrero, AT; Pinto, LG; Verri, WA; Vieira, SM; Zaperlon, AC; Zarpelon, AC, 2013) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Guerrero, AT | 1 |
Zarpelon, AC | 1 |
Zaperlon, AC | 1 |
Vieira, SM | 1 |
Pinto, LG | 1 |
Ferreira, SH | 1 |
Cunha, FQ | 1 |
Verri, WA | 1 |
Cunha, TM | 1 |
1 other study available for pca 4248 and Leukocyte Disorders
Article | Year |
---|---|
The role of PAF/PAFR signaling in zymosan-induced articular inflammatory hyperalgesia.
Topics: Animals; Dihydropyridines; Disease Models, Animal; Dose-Response Relationship, Drug; Hyperalgesia; I | 2013 |